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Aims. We describe a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to quantify and compare simul-
taneously global methylation and hydroxymethylation in human DNA of different tissues. Materials and Methods. Blood and
saliva DNA from fourteen volunteers was processed for epigenetic endpoints using LC-MS/MS and PCR-pyrosequencing
technology. Results. Global DNA methylation was significantly lower in saliva (mean 4.61%± 0.80%), compared to blood samples
(5.70%± 0.22%). In contrast, saliva (0.036%± 0.011%) revealed significantly higher hydroxymethylation compared to blood samples
(mean 0.027%± 0.004%). Whereas we did not find significant correlations for both epigenetic measures between the tissues, a
significant association was observed between global methylation and global hydroxymethylation in saliva DNA. Neither LINE-1
nor Alu elements of blood and saliva correlated, nor were they correlated with the DNA hydroxymethylation of blood or saliva,
respectively. Conclusion. Global DNA methylation and hydroxymethylation of cytosine can be quantified simultaneously by LC-
MS/MS. Saliva DNA cannot be considered as a surrogate for blood DNA to study epigenetic endpoints.
1. Introduction
Epigenetics refers to the study of changes in gene function
that are mitotically and/or meiotically heritable and that do
not entail a change in DNA sequence [1]. Epigenetic mech-
anisms are essential for development (genome imprinting,
X chromosome inactivation, etc.) and differentiation (tran-
scriptional regulation) but can be disrupted by exogenous
agents [2]. Epigenetic changes have been described in relation
to environmental exposure similar to changes observed
in chronic diseases, such as cancer or Alzheimer disease.
The most investigated epigenetic mechanisms include DNA
methylation, histone modifications, and RNA-mediated
silencing [3, 4].
DNA cytosine methylation (5mC) is chemically relatively
stable, but still dynamic epigenetic modifications regulated
by DNA methyltransferases (DNMTs) often occur. These
alterations involve the covalent addition of a methyl group
to the 5-position of cytosine with S-adenosyl methionine
(SAM) as the methyl donor [5, 6]. DNA methylation is
almost exclusively restricted to CpG dinucleotides clustered
within the gene promoter and in repeated elements such as
long (LINE-1) and short (Alu) interspersed elements [5, 7].
Paradoxically, 90% of the methylated CpG lies outside the
coding regions such as CpA, CpT, and CpNpG sites, possibly
to serve as repressors of transposons or viral-like transcripts
[8]. In general, hypermethylation of the DNA promoter
regions inactivates the gene expression and hypomethylation
activates the expression [9]. Aberrant 5mC levels, that is,
global hypomethylation and/or gene-specific hypermethy-
lation or hypomethylation, are observed in diseases like
leukemia and cancer but have also been observed in cells
exposed to carcinogenic agents [10–12].
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Besides 5mC, other epigenetic modifications, such as 5-
hydroxymethylcytosine (5hmC), have been recently discov-
ered in this rapidly evolving field. Significant levels of 5hmC
have been found inDNA fromembryonic stem cells, neurons,
and brain [13]. Even though the biological function is not yet
completely clarified, 5hmC is of special interest in order to
understand the regulation of gene expression and chromatin
structure since it acts as an oxidized intermediate in the active
demethylation of 5mC or even may be the final product of
genome-wide demethylation [13, 14].
The conversion of 5mC to 5hmC is catalysed by ten
eleven translocation (TET) family of proteins (TET1, TET2,
and TET3) which are 2-oxoglutarate (2OG-) and Fe(II)-
dependent dioxygenases. TET1 and TET2 are involved in
the maintenance of embryonic stem cells pluripotency and
cell lineage commitment. TET1 is a fusion partner of the
MLL gene in rare cases of acute myeloid and lymphoid
leukemias. TET2modulates the balance between self-renewal
and differentiation in hematopoietic stem cells, making them
critical for normal myelopoiesis. Loss-of-function of TET2 is
associated with acute myeloid leukemia, myelodysplastic and
myeloproliferative disorders. TET3 contributes to the global
DNA demethylation during the zygotic stage of embryonic
development [14]. These studies highlight the role of TET-
mediated 5-hmC in the developmental processes and the pos-
sibility that altered DNA 5hmC levels can lead to malignancy
[5, 14].
Beside the TET pathway, 5hmC can also be formed
by other mechanisms, for example, UV irradiation of 5mC
in aerated aqueous solution and DNA methyltransferase
reaction of cytosine with formaldehyde.The process of active
DNA demethylation via 5hmC also seems to be mediated by
activation-induced deaminase and DNA glycosylase, which
are involved in deaminating and excision repair [5]. This
indicates that environmental factors might modify the DNA
methylation and hydroxymethylation status and that assays
are needed to measure both total DNA methylation and
hydroxymethylation [15].
In vivo studies on the epigenetic effects of environmental
carcinogens are scarce and have mainly been performed on
human lymphocytes [11, 12]. Blood samples are often the
preferred source of genetic material because they provide
large amounts of cells and in the same sample a wide range
of environmental agents can be determined [16]. The desire
for large-scale epidemiological studies involving thousands
of participants necessitates less invasive and more cost-
efficient procedures for collecting DNA that would facilitate
the trial recruitment [17]. Saliva and buccal swab samples
are described as a noninvasive alternative to collect human
DNA for epigenetic epidemiological studies [18, 19]. Previous
research showed that sufficient amounts of high-quality DNA
could be collected from saliva [20]. The potential advantages
of saliva sample collection compared with blood sample
collection include lower overall cost, lower infection risk,
increased patient convenience, acceptability, and compliance
[21]. However, a potential drawback is the presence of
exogenous DNA (e.g., from bacteria) commonly present in
human saliva and buccal swab samples [22].
In this paper we report on the application of a fast and
sensitive liquid chromatography-tandem mass spectrometry
(LC-MS/MS) method for the simultaneous quantification of
5mC and 5hmC in human DNA from different tissues. We
investigated the association between both epigenetic marks
and compared the results with LINE-1 and Alu methylation,
often used as surrogates for global DNA methylation in
monitoring studies, determined with PCR-pyrosequencing.
In addition, we also investigated for the first time whether
these epigenetic endpoints in DNA of saliva are compara-
ble with DNA from blood of human volunteers in order
to serve as a noninvasive alternative for biomonitoring
purposes.
2. Material and Methods
2.1. Study Design and Population. Fourteen healthy volun-
teers (𝑛 = 4 male, 𝑛 = 10 female) aged less than 45
years were enrolled in this study. Most of the volunteers
(𝑛 = 12) were Caucasian. The participants were recruited
among the scientific staff of the Department of Oral Health
Sciences and the Department of Public Health and Primary
Care and among KU Leuven pregraduate medical students.
All participants received information about the purpose and
objectives of the study and gave written informed consent to
the proposed processing of the data. Participants were asked
to fill out a small questionnaire on general health and lifestyle.
The study was approved by the Commission for Medical
Ethics of UZ Leuven (reference number S53445).
2.2. Sample Collection. Donors were refrained from eating
and drinking for at least 8 hours prior to sample collection
and were asked to rinse their mouth prior to sample taking.
Subjects were asked to produce 2mL unstimulated saliva
using the self-collection kit OG-500 from Oragene (DNA
GenoTek, Ottawa, OT, Canada). Next, blood was drawn from
each participant (three EDTA tubes of 4.5mL).
2.3. DNA Extraction. DNA extraction was performed with
GeneCatcher gDNA Blood Kit for blood samples and Ora-
gene OG-500 kit (DNA GenoTek) for saliva samples. The
quantity and purity of DNAwere determined by a NanoDrop
spectrophotometer.
2.4. DNA Methylation and DNA Hydroxymethylation Anal-
ysis. DNA was analyzed by LC-MS/MS as described pre-
viously [23]. Briefly, isolated genomic DNA samples (1𝜇g)
were enzymatically hydrolyzed to individual deoxyribonu-
cleosides by a simple one-step DNA hydrolysis procedure.
A digest mix was prepared by adding phosphodiesterase
I, alkaline phosphatase, and Benzonase Nuclease to Tris-
HCl buffer. Extracted DNA was hydrolyzed by adding 50 𝜇L
digest mix and incubating at 37∘C for at least 8 h. After
hydrolysis, 900 𝜇L of HPLC-grade water was added to each
sample. Exposure to daylight was avoided over the entire
sample preparation procedure in order to minimize potential
deamination of the target compounds.
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Stock solutions of 5-methyl-2󸀠-deoxycytidine (5mdC),
5-hydroxymethyl-2󸀠-deoxycytidine (5hmdC), and 2󸀠-deoxy-
cytidine (dC) were prepared by dissolving commercial
solid reference standards in HPLC-grade water. Stock
solutions were used to prepare calibration standards. Global
DNAmethylation and hydroxymethylation were obtained by
quantifying 5mdC, 5hmdC, and dCusing ultrapressure liquid
chromatography (UPLC), in combination with tandem mass
spectrometry (MS-MS). LC/MS-MS analysis of the samples
was conducted on a Waters Acquity UPLC, coupled to a
WatersMicromassQuattro PremierMass Spectrometer using
electrospray ionization (ESI). A 15𝜇L aliquot of the sample
was introduced on an Acquity UPLC BEH C
18
, 50mm ×
2.1mm, 1.7 𝜇m column, held at a temperature of 40∘C. The
mobile phase used for the chromatographic separation was a
mixture of 0.1% formic acid in water (A) and 0.1% formic acid
in acetonitrile (B) using the following gradient: the program
was starting at 10% B, increasing linearly to 100% B for 2min,
then held from 2 to 2.1min at 100% B, and finally brought
back to the initial status from 2.1 to 3.0min. A flow rate of
0.35mL/min was applied. The analyses were performed in
the positive ESI mode and a multiple reaction monitoring
(MRM) method was used with argon as the collision gas.
All DNA samples isolated from blood and saliva were
hydrolysed in triplicate. Each sample was then analysed twice
using the LC-MS/MS method. By interpolation from the
established calibration curves, the absolute concentrations,
expressed in ng/mL, for 5mdC, dC, and 5hmdC, present in
the samples (1 𝜇g DNA/mL), could be derived. Together with
every set of 14 volunteer DNA samples, also 3 quality control
(QC) DNA samples have been prepared and analysed, in
order to uncover any potential errors upon sample prepa-
ration and analysis. Global DNA methylation is expressed
as a percentage of 5mdC versus the sum of 5mdC, 5hmdC,
and dC [%Methylation = 5mdC/(5mdC + 5hmdC + dC)],
while global DNA hydroxymethylation is expressed as a
percentage of 5hmdC versus the sum of 5mdC, 5hmdC, and
dC [%Hydroxymethylation = 5hmdC/(5mdC + 5hmdC +
dC)].
2.5. Pyrosequencing of LINE-1 and Alu Elements. Long inter-
spersed nucleotide elements (LINE-1) and the AluSX (Alu)
methylation levels were assessed using PCR-pyrosequencing
of bisulfite-treated DNA. Details of the PCR-pyrosequencing
assays used in the current study are described by Kile, 2010
[7].
2.6. Statistical Analysis. Differences between groups were
analysed by Mann Whitney 𝑈 test for unrelated data and
Wilcoxon signed rank test for related data. Within-tissue
and between-tissue DNA association of methylation and
hydroxymethylation levels was investigated by spearman
correlation.
3. Results
3.1. Characteristics of Participants and Method. A total of
14 healthy subjects (4 males, 10 females) enrolled in the
study. Mean age was 29 years (range 22–43) and BMI ranged
between 20 and 29 (mean 24). Six subjects reported a history
of allergy of dust mites, hay fever, asthma, eczema, penicillin,
or nickel allergy.
The Oragene saliva collection kit yielded sufficient DNA
out of 2mL saliva for all participants with a mean yield
of 20.1 𝜇g DNA (range 6.8–135.4 𝜇g DNA). To perform LC-
MS analysis, a minimum concentration of 20 ng DNA/𝜇L is
required. We extracted on average 42.4 𝜇g DNA (range 1.8–
97.4 𝜇g) out of 4.5mL blood.Theminimum260/280 ratio was
>1.6 for DNA of both tissues.
In order to perform the DNA (hydroxy)methylation
analysis of the samples, a calibration series in HPLC-grade
water was prepared for 5mdC, dC, and 5hmdC and run by
the analytical method. Calibration standards were prepared,
starting from purchased reference standards, in a range of,
respectively, 0.01–5 ng/mL for 5mdC, 0.2–50 ng/mL for dC,
and 0.005–0.07 ng/mL for 5hmdC. The same calibration
standards were used in all experiments. Upon LC/MS-
MS analysis, independent quantification of 5mdC, dC, and
5hmdC was possible since different, unique transitions from
precursor ion to product ion were monitored inMRMmode:
m/z 242.2 → 125.95 for 5mdC (cone voltage 20V, collision
energy 14 eV), m/z 228.1 → 111.9 for dC (cone voltage 18V,
collision energy 12 eV), and m/z 258.0 → 141.9 for 5hmdC
(cone voltage 15V, collision energy 10 eV).The dwell time per
transition was 90ms. Calibrations solutions were analysed
in MRM mode and data processing was based on absolute
peak areas of the different unique product ions. In Figure 1,
the UPLC chromatograms are shown for dC, 5mdC, and
5hmdC, for a volunteer’s blood and saliva sample, as well as
for a calibration standard. For the three different compounds,
calibration curves were constructed, as presented in Figure 2.
For 5mdC and dC the established linear calibration
curves had correlation coefficients >0.99 while for 5hmdC
a correlation coefficient around 0.98 was observed (see
Figure 2). It should be noted however that the concentration
range for 5hmdC is situated far below the ones for 5mdC
and dC. Using an amount of 1 𝜇g digested DNA, the method’s
limits of detection (LODs) for 5 mdC, dC, and 5hmdC were,
respectively, 0.01 ng/mL, 0.01 ng/mL, and 0.005 ng/mL. As a
sample aliquot of 15 𝜇L is injected, these LODs correspond
to amounts of 0.62 fmol 5mdC, 0.66 fmol dC, and 0.29 fmol
5hmdC injected on-column. These LODs are comparable to
previously LC/MS-MS sensitivity data, reported byThuc et al.
(0.5 fmol for 5mdC and 5hmdC) [24].
3.2. Results of %Methylation and %Hydroxymethylation. In
Table 1 the results of %DNAmethylation and%DNA hydrox-
ymethylation are presented. The mean value of global DNA
methylation was significantly (𝑃 = 0.001) lower in saliva
samples (mean 4.61%), compared to blood samples (mean
5.70%). This is in contrast with global hydroxymethylation,
which was significantly higher (𝑃 = 0.001) in saliva samples
(mean 0.036%), compared to blood samples (mean 0.027%).
We did not observe significant differences in global DNA
methylation and hydroxymethylation levels between males
and females. In contrast, 6 individuals with allergy (0.029%
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Figure 1: UPLC chromatograms of the monitored ion transitions for 2󸀠-deoxycytidine (dC), 5-methyl-2󸀠-deoxycytidine (5mdC), and 5-
hydroxymethyl-2󸀠-deoxycytidine (5hmdC): (a) blood sample from a volunteer, (b) saliva sample from the same volunteer, and (c) calibration
standard, containing dC (30.7 ng/mL), 5mdC (1.5 ng/mL), and 5hmdC (0.07 ng/mL).
Table 1: %methylation and % hydroxymethylation in blood and saliva.
Mean Standard deviation Minimum Maximum
Saliva DNA %hydroxymethylation 0.036 0.011 0.019 0.053
Blood DNA %hydroxymethylation 0.027 0.004 0.021 0.032
Saliva DNA %methylation 4.61 0.80 2.36 5.75
Blood DNA %methylation 5.70 0.22 5.25 6.12
± 0.002%, 0.027%–0.032%) showed a small but significant
increase (𝑃 = 0.042) in %hydroxymethylation in DNA
from blood compared to 8 nonallergic participants (0.025%
± 0.004%; 0.021%–0.031%). Neither age nor BMI seemed to
influence the epigenetic endpoints; however only subjects
under 45 were allowed to participate.
Next, we compared %DNA methylation in blood and
saliva and %DNA hydroxymethylation in blood and saliva.
No significant association could be observed (spearman rho
= 0.141, 𝑃 = 0.631 and −0.021, 𝑃 = 0.943) for both epigenetic
endpoints between the two tissues.
We also performed the correlation between %DNA
methylation and %DNA hydroxymethylation in the same
tissue. A significant association was found between %methy-
lation and %hydroxymethylation in saliva DNA (spearman
rho = 0.716; 𝑃 = 0.004) (Figure 3(a)). In blood, no such
significant correlations could be revealed (spearman rho =
0.056; 𝑃 = 0.850) (Figure 3(b)).
3.3. LINE1 andAluMethylation. It is suggested that analyzing
the methylation of DNA repetitive elements can serve as a
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Figure 2: Calibration curves for (a) 2󸀠-deoxycytidine (dC), (b) 5-methyl-2󸀠-deoxycytidine (5mdC), and (c) 5-hydroxymethyl-2󸀠-deoxycyti-
dine (5hmdC).
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Figure 3: Association between %DNA methylation and %DNA hydroxymethylation in (a) saliva samples and (b) blood samples.
surrogate marker for global genomic DNA methylation. We
thus assessed the methylation levels of LINE-1 and Alu ele-
ments of blood and saliva DNA (see Supplementary Table 1
available online at http://dx.doi.org/10.1155/2014/845041). No
significant correlationwas observed between themethylation
levels of blood and salivaAlu elements (spearman rho= 0.297,
𝑃 = 0.303). Methylation levels of blood and saliva LINE1
elements were also not significantly correlated (spearman
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rho = −0.196, 𝑃 = 0.503), although in general lower methyla-
tion levelswere observed for LINE1 andAlu elements in saliva
DNA compared to their methylation levels in blood DNA
(Supplementary Table 1). Also, no significant correlations
were observed in the methylation levels of Alu (spearman
rho = −0.117, 𝑃 = 0.690) and LINE elements (spearman rho =
0.155, 𝑃 = 0.598) of saliva with the DNA hydroxymethylation
in saliva and in themethylation levels of Alu (spearman rho =
0.139,𝑃 = 0.635) and LINE1 elements (spearman rho = 0.099,
𝑃 = 0.737) of blood with the DNA hydroxymethylation level
of blood.
4. Discussion
We described the method for simultaneous quantification
of global DNA methylation and hydroxymethylation by LC-
MS/MS with a high sensitivity and accuracy. The DNA
methylation pattern is in line with a previously published
study [25]. By applying the calibrated assay we showed that
5hmC is present in DNA of different human tissues. Little is
known about the global 5hmC levels in different species. We
report lower global 5hmC contents compared to the other
studies reporting global DNA 5hmC contents in different
nonhuman tissues. Different detection and expression meth-
ods for 5hmC used in small number of studies investigating
the global DNA 5hmC contents make it difficult to compare
them with our findings of global DNA 5hmC levels in blood
and saliva.
GlobalDNAmethylation levels inmales and femaleswere
comparable, which is in line with published data [26]. Gender
also does not seem to affect global hydroxymethylation levels
in DNA from blood or saliva. Since we limited the age at
participation, we cannot draw conclusion on the absence of
an age-effect on global DNA hydroxymethylation. The effect
of age on global DNAmethylation has been widely discussed
[27]. Several studies based on relatively small study samples
(between 76 and 237 subjects) reported an inverse association
between age and genomic 5mC content from blood of healthy
subjects [27]. In contrast, other studies of similar size or larger
(between 32 and 526 samples) reported no association of age
with genomic 5mC content [28].
One of theobjectives was to determine whether saliva
could be a reliable source of DNA and serve as a noninvasive
alternative of bloodDNA in biomonitoring studies. Sufficient
good quality DNA could be extracted from saliva and both
quality and quantity were in line with previously published
data [16, 17, 29]. We did not observe any association between
the two tissues for both epigenetic endpoints (global DNA
methylation andDNAhydroxymethylation), and also no cor-
relationwas observed between the LINE1 andAlu elements of
both tissues. On the one hand, this could be due to the lack
of power due to the small sample size or due to differences in
DNA extraction methods [29].
On the other hand, it is known that saliva samples are
contaminated with DNA from oral bacteria and/or food,
which can overestimate the amount of DNA in these samples
[16, 17, 21]. In our study, participants were refrained from
eating and drinking 8 hours prior to the sample collection
and mouth was rinsed prior to sampling. In addition, the
Oragene sample kit contains an antibacterial agent, which
also prevents the growth of bacteria between the time of
collection and the time of DNA purification. Immediately
after collection, the samples were stored at −80∘C to avoid
bacterial growth. Previous studies have shown that buccal
swabs contain around 11% human DNA, whereas saliva
samples yield on average 68% human DNA [29, 30].
Both blood and saliva contain a variety of cell types,
with different function and half-life, and presumably different
susceptibility to external factors. DNA extracted from blood
samples typically originates from leucocytes (granulocytes,
lymphocytes, and monocytes), whereas human DNA from
buccal swabs mainly stems from exfoliated epithelial cells.
Human DNA from saliva on the other hand is derived from
both leucocytes (granulocytes, lymphocytes, andmonocytes)
and exfoliated epithelial cells [31]. Blood, saliva, and buccal
swabs differ not only in types of the cells they contain, but
also in the viability of the cells. DNA from blood mostly
stems from viable cells, whereas many cells in buccal swabs
are dead (exfoliated cells). These differences might explain
the differences in methylation pattern between the different
tissues.
Our results indicated positive association for global DNA
methylation and hydroxymethylation within the same tis-
sue, that is, saliva. Interestingly, the direction of difference
between global DNA methylation and hydroxymethylation
levels in saliva and blood is opposite to each other, that is,
low global DNA methylation and high global DNA hydrox-
ymethylation in saliva compared to blood. This supports the
hypothesis that 5hmC is involved as an intermediate in the
active demethylation of 5mC. No association in methylation
levels of blood and saliva LINE1 and Alu elements was
observed with the DNA hydroxymethylation levels in blood
and saliva DNA, respectively. Since LINE1 and Alu elements
methylation does not represent the complete cellular pool
of global DNA methylation, this might explain the lack of
this association along with other factors, for example, small
sample size. DNA methylation and hydroxymethylation are
tightly regulated in live cells. Saliva comprises mainly dead
cells, which can explain the low levels of global DNA methy-
lation but high levels of globalDNAhydroxymethylation (i.e.,
dead cells lose control in methylating the repetitive elements
which would increase the global DNA hydroxymethylation)
as compared to the blood, which contains the live cells tightly
regulating their genome. The mechanisms explaining how
this process is controlled and mediated in different cell types
are still unclear [32].
5. Conclusion
In conclusion, both global DNA methylation and hydrox-
ymethylation of cytosine can be quantified simultaneously by
LC/MS-MS. Global DNA methylation and hydroxymethyla-
tion in saliva and blood DNA do not seem to be comparable
and consequently saliva cannot be considered as a surrogate
for blood for epigenetic endpoints. There are indications of
a positive association between global DNA methylation and
hydroxymethylation within the same tissue, that is, saliva.
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6. Future Perspectives
Epigenomics is an active research field driven by the massive
amount of new information. New cellular pathways are
emerging as knowledge of epigenomics is growing. Recently,
the identification and tissue-specific distribution of DNA
hydroxymethylation lead to speculation that DNA hydrox-
ymethylation is not just a passive mark but could play
an important cellular function. Further research in tissue-
specific correlation of different epigenetic factors will help
understand how epigenetic factors play a role in regulating
the activity of genes.
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